Literature DB >> 7812547

Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts.

A De Lassence1, J Fleury-Feith, E Escudier, J Beaune, J F Bernaudin, C Cordonnier.   

Abstract

To establish the diagnosis of alveolar hemorrhage (AH) in cells recovered by bronchoalveolar lavage (BAL), Golde and colleagues created a score based on the hemosiderin content of alveolar macrophages stained with Prussian blue. We used an easier method, calculating the percentage of siderophages among the total alveolar macrophages recovered by BAL. We have retrospectively studied this method in 240 BALs performed in 194 immunocompromised patients. Prussian blue staining was performed on each BAL sample, and the Golde score was calculated for 47 samples chosen at random. The methods were compared for diagnosing AH. The percentage of siderophages correlated well with the Golde score. AH was defined by at least 20% siderophages. This definition was validated by comparison with the method of Kahn and coworkers. AH was present in 87 (36%) of the samples and was significantly associated with four parameters: thrombocytopenia (< 50,000/mm3), other abnormal coagulation parameters, renal failure (creatinine > or = 2.5 mg/dl), and a history of heavy smoking. The diagnosis of AH did not correlate with either the cause or the outcome of pneumonia. AH was seen more frequently in cardiac transplant patients (75%). In our experience, (1) a percentage of siderophages > or = 20% is sufficient and is an easier determinant of the diagnosis of AH than the Golde score; and (2) AH is rarely the sole cause of lung injury and is usually associated with other causes of pneumonia. AH may be considered more as a sign than as a distinct disease in this population.

Entities:  

Mesh:

Year:  1995        PMID: 7812547     DOI: 10.1164/ajrccm.151.1.7812547

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  A rare case of malignant-phase hypertension with pulmonary alveolar hemorrhage.

Authors:  Kazutaka Nanba; Kensei Yahata; Yuko Kikuchi; Chinatsu Okamoto; Koichi Seta; Akira Sugawara
Journal:  Clin Exp Nephrol       Date:  2011-02-01       Impact factor: 2.801

3.  Sequential adjuvant chemoradiotherapy-induced diffuse alveolar haemorrhage in a patient with breast cancer successfully treated with corticosteroid plus recombinant human soluble thrombomodulin.

Authors:  Takamasa Kitajima; Satoshi Marumo; Yurina Maeshima; Motonari Fukui
Journal:  BMJ Case Rep       Date:  2016-10-28

4.  Diffuse alveolar hemorrhage in coumarin users: a fibrosing interstitial pneumonia trigger?

Authors:  Petal A Wijnen; Johny A Verschakelen; Aalt Bast; Otto Bekers; Marjolein Drent
Journal:  Lung       Date:  2012-11-13       Impact factor: 2.584

5.  Diffuse alveolar haemorrhage secondary to warfarin therapy for atrial fibrillation: a case report and literature review.

Authors:  Abdelkarim Waness; Tarek Aldabbagh; Mohammed Harakati
Journal:  BMJ Case Rep       Date:  2009-03-17

6.  Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.

Authors:  N K Rathi; A R Tanner; A Dinh; W Dong; L Feng; J Ensor; S K Wallace; S A Haque; G Rondon; K J Price; U Popat; J L Nates
Journal:  Bone Marrow Transplant       Date:  2014-12-22       Impact factor: 5.483

Review 7.  The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature.

Authors:  Paolo Delvino; Sara Monti; Silvia Balduzzi; Mirko Belliato; Carlomaurizio Montecucco; Roberto Caporali
Journal:  Rheumatol Int       Date:  2018-08-03       Impact factor: 2.631

Review 8.  Primary pulmonary hypertension associated with human immunodeficiency virus infection.

Authors:  R Golpe; B Fernandez-Infante; S Fernandez-Rozas
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

9.  Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancers.

Authors:  So Young Park; So Yeon Lim; Sang-Won Um; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Hye Kyeong Park; Seok Jin Kim; Young Hyuck Im; Myung-Ju Ahn; Gee Young Suh
Journal:  Support Care Cancer       Date:  2013-01-12       Impact factor: 3.603

Review 10.  Update on diffuse alveolar hemorrhage and pulmonary vasculitis.

Authors:  Megan L Krause; Rodrigo Cartin-Ceba; Ulrich Specks; Tobias Peikert
Journal:  Immunol Allergy Clin North Am       Date:  2012-09-28       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.